The 2025 ACS Guideline Update Endorses Ticagrelor Monotherapy ≥1 Month After DAPT Post-PCI: The Unbearable Lightness of Ticagrelor Monotherapy

J Am Coll Cardiol. 2025 Jun 10;85(22):2088-2091. doi: 10.1016/j.jacc.2025.04.046.

¹ The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: roxana.mehran@mountsinai.org.
² The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
³ Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.

No abstract available

Keywords: dual antiplatelet therapy; percutaneous coronary intervention; ticagrelor monotherapy.